ARCHIVES

Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

Moves Forward With Approval From BSA

November 22, 2013

Russian-American Breast Cancer Meeting Canceled

April 14, 1995

A History of NCCN

January 13, 2012

Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure

September 16, 2011

NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected

June 14, 1985